Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-26-020424
Filing Date
2026-04-30
Accepted
2026-04-30 16:06:20
Documents
136
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K form10-k.htm   iXBRL 10-K 3409593
2 EX-4.2 ex4-2.htm EX-4.2 44292
3 EX-23.1 ex23-1.htm EX-23.1 3792
4 EX-31.1 ex31-1.htm EX-31.1 11528
5 EX-31.2 ex31-2.htm EX-31.2 11569
6 EX-32.1 ex32-1.htm EX-32.1 6177
7 GRAPHIC form10-k_001.jpg GRAPHIC 161966
  Complete submission text file 0001493152-26-020424.txt   18812517

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE celu-20251231.xsd EX-101.SCH 167673
9 XBRL CALCULATION FILE celu-20251231_cal.xml EX-101.CAL 131890
10 XBRL DEFINITION FILE celu-20251231_def.xml EX-101.DEF 711375
11 XBRL LABEL FILE celu-20251231_lab.xml EX-101.LAB 1129400
12 XBRL PRESENTATION FILE celu-20251231_pre.xml EX-101.PRE 891851
139 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 3064814
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

EIN.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38914 | Film No.: 26925095
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)